Learn about the government's decision to lower GST on drugs and medical devices, effective from September 22, 2025, and how it impacts product ...

Under the new notification issued by the Ministry of Consumer Affairs, the manufacturers and importers no longer need to ...

In a coordinated move to ensure patients benefit from the recent GST rate cut on drugs and medical devices effective 22nd ...

Centre permits revised MRPs on unsold stock after GST changes till 31 Dec 2025, subject to conditions on stamping, display, and consumer ...

NPPA directs firms to issue revised price lists instead of recalling stock; compliance to be ensured at retailer level ...

Jharkhand DC issues guidelines on MRP revisions of medicines post-GST amendments: Peethaambaran Kunnathoor, Chennai Thursday, September 11, 2025, 08:00 Hrs [IST] In response to th ...

The Centre has allowed FMCG firms to revise MRPs on unsold stocks until Dec 31, 2025, easing concerns over GST 2.0 rate ...

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, has clarified that drug manufacturers need not recall or re-label medicines already released in the ...

The GST Council has revised rates of a range of fast-moving consumer goods (FMCG), effective from September 22, reducing them ...

In the circular, dated September 17, the department noted that the revised GST structure will come into force from September ...

India’s Department of Consumer Affairs has allowed manufacturers to revise the MRP on unsold stock following changes in GST ...

Separately, the finance ministry is studying mechanisms to help businesses deal with potential losses from new inverted duty ...